Search research articles
Contact Us
Filters
Showing results (61-70 of 68) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 68 results.
Cancer
|
December 24, 1997
Anti-carcinoembryonic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma: are carcinoembryonic antigen and somatostatin receptor expression prognostic factors?
T M Behr, S Gratz, P M Markus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 30, 1999
Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential
T M Behr, M Béhé, C Angerstein, et al.
Anticancer Research
|
September 2, 1999
Radioimmunotherapy of colorectal cancer in small volume disease and in an adjuvant setting: preclinical evaluation in comparison to equitoxic chemotherapy and initial results of an ongoing phase-I/II clinical trial
T M Behr, S Memtsoudis, V Vougioukas, et al.
Nuclear Medicine Communications
|
August 16, 2001
(99m)Tc-E-selectin binding peptide for imaging acute osteomyelitis in a novel rat model
S Gratz, M Béhé, O C Boerman, et al.
International Journal of Cancer
|
August 4, 1998
Experimental studies on the role of antibody fragments in cancer radio-immunotherapy: Influence of radiation dose and dose rate on toxicity and anti-tumor efficacy
T M Behr, S Memtsoudis, R M Sharkey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 1999
Low- versus high-dose radioimmunotherapy with humanized anti-CD22 or chimeric anti-CD20 antibodies in a broad spectrum of B cell-associated malignancies
T M Behr, B Wörmann, M Gramatzki, et al.
Cancer Research
|
June 11, 1999
High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model
T M Behr, M Béhé, M G Stabin, et al.
Beneficial Microbes
|
September 25, 2024
Butyrate-producing bacteria as probiotic supplement: beneficial effects on metabolism and modulation of behaviour in an obesity mouse model
A M Garcia-Serrano, C Skoug, U Axling, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 68) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 68 results.
Cancer
|
December 24, 1997
Anti-carcinoembryonic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma: are carcinoembryonic antigen and somatostatin receptor expression prognostic factors?
T M Behr, S Gratz, P M Markus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 30, 1999
Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential
T M Behr, M Béhé, C Angerstein, et al.
Anticancer Research
|
September 2, 1999
Radioimmunotherapy of colorectal cancer in small volume disease and in an adjuvant setting: preclinical evaluation in comparison to equitoxic chemotherapy and initial results of an ongoing phase-I/II clinical trial
T M Behr, S Memtsoudis, V Vougioukas, et al.
Nuclear Medicine Communications
|
August 16, 2001
(99m)Tc-E-selectin binding peptide for imaging acute osteomyelitis in a novel rat model
S Gratz, M Béhé, O C Boerman, et al.
International Journal of Cancer
|
August 4, 1998
Experimental studies on the role of antibody fragments in cancer radio-immunotherapy: Influence of radiation dose and dose rate on toxicity and anti-tumor efficacy
T M Behr, S Memtsoudis, R M Sharkey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 1999
Low- versus high-dose radioimmunotherapy with humanized anti-CD22 or chimeric anti-CD20 antibodies in a broad spectrum of B cell-associated malignancies
T M Behr, B Wörmann, M Gramatzki, et al.
Cancer Research
|
June 11, 1999
High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model
T M Behr, M Béhé, M G Stabin, et al.
Beneficial Microbes
|
September 25, 2024
Butyrate-producing bacteria as probiotic supplement: beneficial effects on metabolism and modulation of behaviour in an obesity mouse model
A M Garcia-Serrano, C Skoug, U Axling, et al.
Page
of 7